Gainers
- Omega Therapeutics (NASDAQ:OMGA) shares increased by 99.6% to $5.45 during Thursday's regular session. The market value of their outstanding shares is at $300.5 million.
- Avenue Therapeutics (NASDAQ:ATXI) shares increased by 56.08% to $0.27. The company's market cap stands at $3.6 million.
- Dyne Therapeutics (NASDAQ:DYN) stock rose 30.28% to $19.24. The market value of their outstanding shares is at $1.1 billion.
- Adicet Bio (NASDAQ:ACET) shares moved upwards by 25.0% to $2.2. The company's market cap stands at $94.9 million.
- Bright Health Gr (NYSE:BHG) stock increased by 24.15% to $11.36. The company's market cap stands at $90.6 million.
- Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 20.22% to $5.23. The market value of their outstanding shares is at $189.2 million.
Losers
- SELLAS Life Sciences Gr (NASDAQ:SLS) stock decreased by 35.7% to $0.58 during Thursday's regular session. The company's market cap stands at $18.6 million.
- Relmada Therapeutics (NASDAQ:RLMD) stock declined by 30.69% to $3.14. The market value of their outstanding shares is at $94.5 million.
- LifeMD (NASDAQ:LFMD) shares declined by 29.99% to $5.44. The company's market cap stands at $213.2 million.
- OPKO Health (NASDAQ:OPK) stock declined by 28.13% to $1.08. The company's market cap stands at $833.4 million.
- Jin Medical International (NASDAQ:ZJYL) stock declined by 25.83% to $149.09. The company's market cap stands at $1.1 billion.
- ABVC BioPharma (NASDAQ:ABVC) stock fell 20.37% to $1.54. The company's market cap stands at $11.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ACETAdicet Bio Inc
$0.66462.85%
ATXIAvenue Therapeutics Inc
$0.800090.5%
DYNDyne Therapeutics Inc
$19.680.05%
HOWLWerewolf Therapeutics Inc
$1.13-%
LFMDLifeMD Inc
$5.080.40%
OPKOPKO Health Inc
$1.340.75%
RLMDRelmada Therapeutics Inc
$3.27-0.61%
SLSSELLAS Life Sciences Group Inc
$1.51-%
ZJYLJin Medical International Ltd
$0.25501.92%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
